CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain MetastasesUpdated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial
Author
A. Carey Lisa
A. Hurvitz Sara
+25Â more
Abramson Verdana
Anders Carey
Bachelot Thomas
Borges Virginia
Cameron David A
Chien Jo
Curigliano Giuseppe
Feng Wentao
Gelmon Karen
Hortobagyi Gabriel
K. Murthy Rashmi
Krop Ian
L. Bedard Philippe
Loi Sherene
Loibl Sibylle
Mueller Volkmar
Oliveira Malfada
P. Di Giovanna Michael
Paplomata Elisavet
Pegram Mark
Ramos Jorge
Slamon Dennis
U. Lin Nancy
Winer Eric
Zelnak Amelia
Publication venue
'American Medical Association (AMA)'
Publication date
01/12/2022
Field of study
Get PDF
Edinburgh Research Explorer